This document provides information on the herbal medicine Crotonis Semen (Croton seed), including its common name, botanical name, toxicity level, indications for use, pharmacological actions, cautions, and major constituents. It states that Croton seed is very toxic and carcinogenic, especially in its oil form, which can promote radiation transformation in animal studies. While used topically for conditions like scabies and eczema, it requires pretreatment and caution against use in pregnancy due to its toxicity.
This document discusses methylation of the MeCP2 gene and its potential intergenerational effects. It covers:
1) MeCP2 is a methyl-CpG binding protein involved in transcriptional repression. Mutations can cause Rett syndrome.
2) The structure and function of the MeCP2 protein, which binds to methylated DNA and recruits histone deacetylases to repress gene transcription.
3) The study aims to analyze relationships between maternal smoking, MeCP2 gene methylation levels, and baby phenotypes like weight, length and gestational age.
This document discusses the history and structure of US venture capital. It notes that venture capital provides funding for early-stage companies in exchange for equity. After starting with wealthy individual investors, the venture capital industry grew in the post-World War II era through firms like ARDC. The 1958 Small Business Investment Act helped licensing more VC firms. Major Silicon Valley firms like Kleiner Perkins emerged in the 1970s, fueling technology industry growth. The document outlines the typical structure of venture capital funds and firms.
This document provides information on the herbal medicine Crotonis Semen (Croton seed), including its common name, botanical name, toxicity level, indications for use, pharmacological actions, cautions, and major constituents. It states that Croton seed is very toxic and carcinogenic, especially in its oil form, which can promote radiation transformation in animal studies. While used topically for conditions like scabies and eczema, it requires pretreatment and caution against use in pregnancy due to its toxicity.
This document discusses methylation of the MeCP2 gene and its potential intergenerational effects. It covers:
1) MeCP2 is a methyl-CpG binding protein involved in transcriptional repression. Mutations can cause Rett syndrome.
2) The structure and function of the MeCP2 protein, which binds to methylated DNA and recruits histone deacetylases to repress gene transcription.
3) The study aims to analyze relationships between maternal smoking, MeCP2 gene methylation levels, and baby phenotypes like weight, length and gestational age.
This document discusses the history and structure of US venture capital. It notes that venture capital provides funding for early-stage companies in exchange for equity. After starting with wealthy individual investors, the venture capital industry grew in the post-World War II era through firms like ARDC. The 1958 Small Business Investment Act helped licensing more VC firms. Major Silicon Valley firms like Kleiner Perkins emerged in the 1970s, fueling technology industry growth. The document outlines the typical structure of venture capital funds and firms.
1. The document discusses critical periods of human embryonic development from the first through eighth weeks. During this time, organ systems develop from the three germ layers and major malformations can occur if development is disrupted.
2. Specific processes discussed include gastrulation, neurulation, heart development and septation, palate formation, and limb bud emergence.
3. Teratogens acting during critical periods can cause defects such as neural tube defects, holoprosencephaly, cardiac defects, and limb abnormalities. Disorders from disrupted development of neural crest cells are also examined.
1) The document discusses the principles of teratology, which is the study of abnormal fetal development. Some key principles discussed include that susceptibility to teratogenesis depends on factors like genetics and environment.
2) Several recognized human teratogens are discussed like thalidomide, accutane, and alcohol. Historical cases of adverse drug effects in pregnancy from drugs like thalidomide, bendectin, and diethylstilbestrol are also summarized.
3) Methods for evaluating the safety and risks of drugs in pregnancy are covered, including studies in animals and humans as well as systems used by organizations like the FDA and KBS to classify risk. The role of teratology information services in drug
In pharmaceutical area, patent protection on innovatio is critical. In other aspect, it is critical to secure rooms for oeprating businesses without worrying about patent infringements. Slides have pratical strategy and advices for both sides.
이제 기계는 사람의 말을 구분하고, 사람이 바라보는 것이 무엇인지를 인지하는 단계까지 진화했습니다. 점차적으로 인간이 이해하는 것을 기계도 이해하려고 노력하고 있습니다. 기계학습의 분야는 어떤 놀라운 혁신이 일어나고 있을까요? 기계학습의 혁신을 통해 인간의 배움과 성장에 관한 경이로움을 재발견 할 수 있습니다.
Safety of Mebendazole Use During Lactationmothersafe
This case series study evaluated the safety of mebendazole use in 45 lactating women and their infants. Mebendazole was administered using single or repeated doses and was well tolerated by both the mothers and infants, with no adverse effects observed in infants. Mild GI irritability occurred in two treated mothers. This study provides the first evidence that mebendazole is safe for use in breastfeeding.
Systems biology aims to understand biological processes through modeling dynamic networks representing interactions between components. It analyzes multi-omics data from projects like TCGA using bioinformatics tools. TCGA collected genomic data from thousands of cancer patients across 20 tumor types to identify common pathways. Combinatorial Adaptive Resistance Therapy aims to target upregulated survival pathways and downregulated cell death pathways that cause adaptive resistance to targeted agents through rational drug combinations. Future strategies will use deep profiling of patients to define molecularly targeted drug cocktails and adapt therapies based on longitudinal molecular monitoring.
Note (2017-07-12): a more recent version of this slide has been released. https://www.slideshare.net/ByoungHeeKim1/20170629-osia-final
Introduction to deep learning approaches for artificial intelligence (with some practice materials) (mostly in Korean)
(서울대학교 인지과학협동과정, 인지과학방법론 2016년 2학기 강의)
Bridge Biotherapeutics has recently signed a major global licensing agreement for their drug BBT-877 for treating IPF and other indications. The total licensing fee was over 1.1 billion euro, with an upfront payment of 45 million euro. The partner, BI, is the market leader in IPF.
Bridge Biotherapeutics is a 4-year-old Korean biotech company with a pipeline of 3 drug candidates for ulcerative colitis, pulmonary fibrosis, and NSCLC. They have adopted a global strategy of finding innovations locally, financing regionally, and developing drugs globally, with a focus on small molecules, areas with less competition, and first-in-class therapies. They utilize global talents and operate
1. The document discusses critical periods of human embryonic development from the first through eighth weeks. During this time, organ systems develop from the three germ layers and major malformations can occur if development is disrupted.
2. Specific processes discussed include gastrulation, neurulation, heart development and septation, palate formation, and limb bud emergence.
3. Teratogens acting during critical periods can cause defects such as neural tube defects, holoprosencephaly, cardiac defects, and limb abnormalities. Disorders from disrupted development of neural crest cells are also examined.
1) The document discusses the principles of teratology, which is the study of abnormal fetal development. Some key principles discussed include that susceptibility to teratogenesis depends on factors like genetics and environment.
2) Several recognized human teratogens are discussed like thalidomide, accutane, and alcohol. Historical cases of adverse drug effects in pregnancy from drugs like thalidomide, bendectin, and diethylstilbestrol are also summarized.
3) Methods for evaluating the safety and risks of drugs in pregnancy are covered, including studies in animals and humans as well as systems used by organizations like the FDA and KBS to classify risk. The role of teratology information services in drug
In pharmaceutical area, patent protection on innovatio is critical. In other aspect, it is critical to secure rooms for oeprating businesses without worrying about patent infringements. Slides have pratical strategy and advices for both sides.
이제 기계는 사람의 말을 구분하고, 사람이 바라보는 것이 무엇인지를 인지하는 단계까지 진화했습니다. 점차적으로 인간이 이해하는 것을 기계도 이해하려고 노력하고 있습니다. 기계학습의 분야는 어떤 놀라운 혁신이 일어나고 있을까요? 기계학습의 혁신을 통해 인간의 배움과 성장에 관한 경이로움을 재발견 할 수 있습니다.
Safety of Mebendazole Use During Lactationmothersafe
This case series study evaluated the safety of mebendazole use in 45 lactating women and their infants. Mebendazole was administered using single or repeated doses and was well tolerated by both the mothers and infants, with no adverse effects observed in infants. Mild GI irritability occurred in two treated mothers. This study provides the first evidence that mebendazole is safe for use in breastfeeding.
Systems biology aims to understand biological processes through modeling dynamic networks representing interactions between components. It analyzes multi-omics data from projects like TCGA using bioinformatics tools. TCGA collected genomic data from thousands of cancer patients across 20 tumor types to identify common pathways. Combinatorial Adaptive Resistance Therapy aims to target upregulated survival pathways and downregulated cell death pathways that cause adaptive resistance to targeted agents through rational drug combinations. Future strategies will use deep profiling of patients to define molecularly targeted drug cocktails and adapt therapies based on longitudinal molecular monitoring.
Note (2017-07-12): a more recent version of this slide has been released. https://www.slideshare.net/ByoungHeeKim1/20170629-osia-final
Introduction to deep learning approaches for artificial intelligence (with some practice materials) (mostly in Korean)
(서울대학교 인지과학협동과정, 인지과학방법론 2016년 2학기 강의)
Bridge Biotherapeutics has recently signed a major global licensing agreement for their drug BBT-877 for treating IPF and other indications. The total licensing fee was over 1.1 billion euro, with an upfront payment of 45 million euro. The partner, BI, is the market leader in IPF.
Bridge Biotherapeutics is a 4-year-old Korean biotech company with a pipeline of 3 drug candidates for ulcerative colitis, pulmonary fibrosis, and NSCLC. They have adopted a global strategy of finding innovations locally, financing regionally, and developing drugs globally, with a focus on small molecules, areas with less competition, and first-in-class therapies. They utilize global talents and operate
2017 MK 바이오헬스
- 스타오디션 & 창업 페스티벌.... 에서 기조강연 6번째로 창업 선배의 조언이라는 주제하에 발표한 내용이다.
1987년 이후로 제약바이오의 생태계를 .. 사막에서 나무 하나 심으며 시작하신 선배들이 한땀 한땀 이루어낸 것이.. 오늘 2017년도 대학민국에서 우리가 누리고 있는 꽤 성장한 창업 및 스타트업 생태계이다.
선배들이. 마치. walking off the cliff 하며 만들어, 이제 off-the-cliffer들이 한둘씩 늘어나고 또 늘어나 꽤 큰 무리가 되었다.
감사함으로 현재의 생태계를 누리고 또한 더 좋은 생태계를 함께 만들어가자.
Koreas has history of 30 years in biopharma sector and started exploring home-grown novel sciences recently. More entrepreneurial activities by KASBP is being encouraged to capitalize on US-based KASBP and Korean growing ecosystem.
Recent trends and changes in r&d :bd among korean biopharmasJames Jungkue Lee
The Korean biopharma industry has undergone profound changes in recent years. Hanmi Pharma's successful deals in 2015 increased confidence in Korean biotechs and attracted interest from foreign companies. As the industry matures, biotechs are becoming more virtualized while continuing to develop novel science from academia. Current trends include increased expertise in business development, more clinical-stage assets globally, and new startups emerging from academia and established companies. Korean companies are also increasingly participating in global business development as sources of innovation.
Recent trends and changes in R&D and BD among Korean biopharmasJames Jungkue Lee
The Korean biopharma industry has undergone profound changes in recent years. Hanmi Pharma's successful deals in 2015 increased confidence in Korean biotechs and attracted interest from foreign companies. As the industry matures, biotechs are becoming more virtualized while continuing to develop novel science from academia. Current trends include increased expertise in business development, more clinical-stage assets globally, and new startups emerging from academia and established companies. Korean companies are also increasingly participating in the global biopharma industry as sources of innovation through deals, investments, and joint ventures.
2016년 1월 21일, 제1회 한미오픈이노베이션포럼에서 발표한 내용입니다.
바이오텍들이 오픈이노베이션 역량을 강화하기 위하여 3개 I (Invention, Intelligence, Interaction) 요소 역량을 강화하기를 제안한다.
Invention: 고유혁신창출능력. 과학 혹은 지식을 지적 자산 (asset)화하는 것이다. 여기서 특히 특허에 대한 투자가 필요하다. 특허의 청구항을 설계하고, 그에 필요한 실시예들을 확인하여 좋은 특허를 만드는 것과 개별국진입시 빅파마들의 기준에 맞는 20여개국 진입이 필요함을 강조하였다.
Intelligence: 환자의 니즈, 경쟁사 동향, 잠재협력대상자들의 상황과 니즈 등에 대한 정보 취득에 국내 바이오텍들이 더 투자하기를 부탁했다.
Interaction: 잠재적 협력대상자들과의 상호작용을 통하여 더 많은/정확한 수요를 파악하면서 동시에 좀더 전문성있는 접촉 역량을 키워나갈 수 있음을 강조했다.
Korean bio pharma industry partnering trends at BioKorea 2015James Jungkue Lee
The document discusses trends in R&D partnering for the Korean bio/pharma industry from 1987 to the present. It notes that initially in the late 1980s and 1990s, large Korean conglomerates licensed early-stage compounds to major Western companies. From 2000-2010, mid-sized Korean companies and biotechs began partnering novel compounds. Recent deals include a biotech licensing a next-gen botulinum toxin to J&J, a biotech forming a broad collaboration with BMS using an antisense technology platform, and a large Korean company licensing a first-in-class BTK inhibitor to Eli Lilly. The future of the industry looks promising as the gap with Western counterparts continues to narrow
The document discusses various types of antibody therapeutics beyond conventional antibodies, including:
1) Antibody drug conjugates that link cytotoxic payloads like chemotherapy agents to antibodies to target cancer cells.
2) Multispecific antibody formats that bind two or more antigens, like bispecific T-cell engagers that recruit T cells to kill cancer cells.
3) Non-antibody protein scaffolds that mimic the binding properties of antibodies but have advantages like smaller size and greater stability. These include domains from lipocalins, adnectins, and affibodies.
4) Various engineered antibody formats like antibody fragments, conjugated antibodies, and common light chain antibodies that modify properties like half-
Antibody mimetics is defined as new scaffold protein which can provide bidning affinity to various antigens. Summary of current antibody scaffold proteins and strategy to differentiate from existing scaffolds.
This presentation was made at ABBF (Asia BioBusiness Forum) in Il-San, Korea in 2012. And it was used also for Biopharmaceutical Project Management Education Course provided by Korea Bio Association. I wanted to review the history of Korean biopharma from the inception and provide different perspectives on how to realize Korean companies assets' potential globally.
15. 시사점!
화려한 시절은 지난 듯합니다.!
Proc. Natl. Acad. Sci, USA
Vol. 82, pp. 7580-7584, November 1985!
Biochemistry!
3. 동반진단 등 진단의 중요 대두!
Cloning and Expression of the human erythropoietin gene!
•
Herceptin과 HER2/neu!
•
Foundation Medicine (NGS 기반 암 유전자 분석)!
*Amgen, 1900 Oak Terrace Lane, Thousand Oaks, CA 91320; and +Department of Biochemistry and Molecular Biology, The University
of Chicago, Chicago, IL 60637!